Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Calcitriol Delivery

PreclinicalSmall molecule

AAl-Azhar University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Maxillary Canine RetractionNot yet recruiting

Maxillary Canine RetractionPreclinical

Not yet recruiting

Timeline

Expected Milestones

Q4 2026

N/ANot yet recruiting

Maxillary Canine Retraction

NCT07200349

Clinical

Trials by Indication[1]

Maxillary Canine Retraction1 trial

Clinical Evaluation of Local Calcitriol Delivery on Maxillary Canine Retraction

Not yet recruiting·—·N/A·NCT07200349·22 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Calcitriol Delivery. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Calcitriol Delivery compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Calcitriol Delivery. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Al-Azhar University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAl-Azhar University

Related News